Showing results (841-850 of 1,023) with videos related to

Sort By:
Pageof 103
The Biochemical Journal|April 16, 1998
Cloning, expression and map assignment of chicken prosaposinN Azuma, H C Seo, O Lie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDSH Hendel, S Caillat-Zucman, H Lebuanec, et al.
Clinical Biochemistry|October 4, 2011
The stability of markers in dried-blood spots for recommended newborn screening disorders in the United StatesB W Adam, E M Hall, M Sternberg, et al.
Leukemia & Lymphoma|July 1, 1994
Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignanciesL C Platanias, M J Ratain, S O'Brien, et al.
Environmental Science & Technology|January 15, 2013
Field-scale transport and transformation of carboxymethylcellulose-stabilized nano zero-valent ironRichard L Johnson, James T Nurmi, Graham S O'Brien Johnson, et al.
Surgical Endoscopy|May 30, 2019
Comparing the efficacy of initial percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography with stenting for relief of biliary obstruction in unresectable cholangiocarcinomaS O'Brien, N Bhutiani, M E Egger, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2020
Knowledge and Practices in the Diagnosis and Treatment of Corneal Infections by Nepalese Pharmaceutical Shop WorkersSadhan Bhandari, John M Nesemann, Ram Prasad Kandel, et al.
The Medical Journal of Australia|October 2, 2022
Modern paradigms for prostate cancer detection and managementIsabella Sc Williams, Aoife McVey, Sachin Perera, et al.
Journal of Vascular Surgery|April 11, 2020
Improved survival with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic limb-threatening ischemiaSikandar Z Khan, Monica S O'Brien-Irr, Mariel Rivero, et al.
Leukemia|July 21, 2006
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylateE Jabbour, H Kantarjian, D Jones, et al.
Pageof 103